Posted on 10/05/2021 9:55:40 AM PDT by Olog-hai
AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease.
The Anglo-Swedish company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency authorization for COVID-19 prevention. If authorized, the drug would likely be limited to people with compromised immune systems who don’t get sufficient protection from vaccination.
“First and foremost we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine,” said Menelas Pangaloa, AstraZeneca’s head of research and development. “But ultimately it will be up to health authorities to work out who they choose to immunize.”
Pangaloa said the company’s long-acting formulation is designed to boost immunity for up to one year, compared with existing drugs that offer a month or two of protection. …
(Excerpt) Read more at apnews.com ...
No, there are alternatives. Isn’t it an abuse to issue EUA?
That’s what the current “administration” thrives on.
Yes its an intramuscular injection and that leads to release for about a week or so but 3 months?? And they are claiming a therapeutic "prophylactic" efficacy of 12 months??
Not a lot published on all this so its hard to determine how they doing all this but if it works - cool.
Antibody treatment? What will the Diden assministraion, including Fauci, be saying and doing against this anti-vax treatment/
Isn't that what all the previous, widely administered, apparently ineffective “vaccines” should have done? I have always thought a vaccine should stimulate the body's creation of sufficient levels of antibodies so the immune system could and would fight off the disease. Evidently, the Moderna, Pfizer and J&J “vaccines” are not vaccines at all.
If this new stuff does indeed have a 12 month prophylaxis that will totally undermine the Dire Need for everyone to get the jab.
No word yet on side effects from this Astra monocolonal treatment - if it has a low adverse effects profile then this could easily replace jabs for most at risk.
Astravermectin?
Yes - thats what they should have done. But now it appears their duration of efficacy is very short - adding further to the de-classifying this mRNA approach as a vaccine.
From the article: “If authorized, the drug would likely be limited to people with compromised immune systems who don’t get sufficient protection from vaccination.”
So come back in 12 months with a study of actual patients so long term effects have a chance to develope.
Perhaps Astroxychloroquine and Astromycin too.
Once approved for that, and the drug is in use, the sponsor will seek expanded indications using the data for support.
If someone gets covid, and a few days later gets monoclonal antibodies, do they have natural antibodies plus the monoclonal ones?
And how long would that combination last?
Super important question - the problem with infections is the lag period our immune system has. It takes a few days for the body to make IgM antibodies and a few more days to make IgG antibodies.
The IgMs are brawlers - they can fight but not that effectively. The IgGs are the Roman Legion - they come in large numbers and are super specific to the proteins on the microbe surface.
During this lag period people can get really sick. So getting the monoclonal antibodies is something needed right away.
Or if they can last 12 months - get it and be protected.
thanks for the info about the IgG and IgM antibodies !
I think the word you’re looking for is “money grubbing”.
AstraZeneca is involved in bribes in Australia.
The execs should be arrested and sent to the prison called Australia.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.